Fragmentomics pioneer showcases DELFI-TF treatment monitoring solution alongside early detection capabilities at a premier oncology research event BALTIMORE and PALO...
Fragmentomics pioneer showcases DELFI-TF treatment monitoring solution alongside early detection capabilities at a premier oncology research event BALTIMORE and PALO...
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection,...
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection,...
Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour ...
All patients achieved 20/30 or better best corrected distance visual acuity (BCDVA)Significant IOP reduction at 18 months was also demonstrated...
ADC assay now available through ABS; customer study proves IO60 is a spatial workhorseMARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE)...
Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs,...
The new AI agent integrates the benefits of an LLM and KRR to deliver private, secure, personalized health recommendations based...
The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of...
DURHAM, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in multi-omics innovation, today announced its presence at...
KANAZAWA, Japan, April 23, 2025 /PRNewswire/ -- Scientists at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University have captured real-time footage showing how...
Cong Yu joins a fast-growing team as Dandy looks to triple engineering investment in 2025NEW YORK, April 22, 2025 (GLOBE...
R&D funding accelerates the transition from research to impactBOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech announced today that...
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation...
The presentation will be webcast at 10:30 AM ET on April 22, 2025POMPANO BEACH, Fla., April 21, 2025 (GLOBE NEWSWIRE)...
Company to highlight preclinical study of ARV-393, an investigational PROTAC BCL6 degrader, in combination with standard of care therapiesNEW HAVEN,...
SpaceX's 32nd resupply mission for NASA includes ISS National Lab-sponsored biomedical research, physical sciences projects, technology demonstrations, and NSF-funded science...
PHILADELPHIA, April 17, 2025 /PRNewswire/ -- The Edna Bennett Pierce Prevention Research Center (PRC) at Penn State and ERPHealth, a...
Researchers to launch a new project leveraging the ISS National Lab to Improve Nanomaterial Production for Future Osteoarthritis and Cancer...